Endpoint in ovarian cancer xenograft model predicted by nighttime motion metrics.

Saved in:
Bibliographic Details
Title: Endpoint in ovarian cancer xenograft model predicted by nighttime motion metrics.
Authors: Nwagwu CD; OncoSynergy, Inc., Greenwich, CT, USA., Defensor E; Vium, Inc., San Mateo, CA, USA., Jiang MY; OncoSynergy, Inc., Greenwich, CT, USA., Rolle-McFarland DA; OncoSynergy, Inc., Greenwich, CT, USA., Carbonell AE; OncoSynergy, Inc., Greenwich, CT, USA. anne-marie@oncosynergy.com., Carbonell WS; OncoSynergy, Inc., Greenwich, CT, USA.
Source: Lab animal [Lab Anim (NY)] 2020 Aug; Vol. 49 (8), pp. 227-232. Date of Electronic Publication: 2020 Jul 20.
Publication Type: Journal Article
Journal Info: Publisher: Nature America Country of Publication: United States NLM ID: 0417737 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1548-4475 (Electronic) Linking ISSN: 00937355 NLM ISO Abbreviation: Lab Anim (NY) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1548-4475
DOI:10.1038/s41684-020-0594-1